ASCO Clinical Cancer Advances 2019 Names Advance of the Year: Progress in Treating Rare Cancers

January 31, 2019 – Over the past year, major research advances provided new treatment options for patients with rare, difficult-to-treat cancers. In recognition of these achievements, ASCO named “Progress in Treating Rare Cancers” as the Advance of the Year. To continue the forward momentum, ASCO also debuted its list of research priorities to accelerate progress against cancer. These and additional milestones in cancer research are featured in Clinical … (leggi tutto)